Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nicolaus Reifart Added: 3 years ago
Definition and Prevalence Chronic coronary occlusions (CTOs) are defifined as lesions with Thrombolysis in Myocardial Infarction (TIMI) 0 flow older than three months (either angiographically proven or with high clinical likelihood). 1 According to a recent Canadian registry, CTOs are detected in about 30 % of patients with symptomatic coronary artery diseases (CAD).2 Likewise a very large German… View more

MI/ACS

Intervention
Author(s): Vijay S Ramanath , Craig Thompson Added: 3 years ago
Coronary chronic total occlusions (CTOs) remain one of the most challenging percutaneous challenges in interventional cardiology, with technical success rates of only ~50–70 %.1,2 This lesion subset often poses the greatest risk and often requires techniques and equipment not typically utilised for more acute coronary lesions. However, successful percutaneous CTO revascularisation is associated… View more

MI/ACS

Intervention
Author(s): Konstantinidis Nikolaos , Sianos Georgios Added: 3 years ago
Saphenous vein grafts (SVGs), despite their inherent inferiority to arterial conduits, still remain the type of grafts most commonly used during coronary artery bypass grafting (CABG).1 The natural and post-interventional biological behaviour of SVGs differ from that of native coronary vessels, increasing the risk of restenosis.2 SVG disease after CABG is a strong predictor of mortality.3 In a… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Dr Robert Garbo has been an Interventional Cardiologist since 1999. He was Head of the Cath Lab at San Giovanni Bosco Hospital from2005- 2020, director of the CTO PCI, CHIP, and complex PCI programs over the last 15 years. He has operated more than 2200 CTO PCI, of which 1100 with retrogradeapproach. Proctor for CTO PCI programs in Italy, Europe( France, Poland, Romania, Czeck republic,… View more
Job title: Director of Cardiology and Catheterisation Laboratories
Dr Shigeru Saito is the Director of Cardiology and Catheterisation Laboratories, at Shonan Kamakura General Hospital in Kamakura,Japan. Dr Saito is one of the leading supporters and practitioners of transradial coronary intervention (TRI) in the world. As an evangelist for TRI, he has travelled the world to teach and demonstrate the benefits and techniques of this alternative to the femoral… View more
Author(s): Nicolaus Reifart Added: 3 years ago
Definition and Prevalence Nowadays it is widely accepted to define chronic total occlusions (CTOs) of the coronary artery as lesions with thrombolysis in myocardial infarction 0 flow for more than three months (either angiographically proven or with high clinical likelihood).1 Occlusions of less than four weeks following an acute infarction are defined as acute or subacute and occlusions of… View more

Prevention & Chronic Conditions
Author(s): Nikolaos Konstantinidis , Georgios Sianos Added: 3 years ago
Coronary chronic total occlusions (CTOs) are identified in up to one-third of all patients referred for diagnostic coronary angiography,1 with an incidence increasing with age.2 CTOs still represent the most technically challenging lesion subset that interventional cardiologists face. The benefits of successful CTO recanalisation are related to improved survival,3,4 most notably in patients with… View more

Intervention
Author(s): Alfredo Galassi , Aaron Grantham , David Kandzari , et al Added: 3 years ago
Section A Techniques for Chronic Total Occlusions Revascularisation Access Route, Guiding Catheter Selection and Contralateral Injection The femoral approach is the preferred access route by most operators. However, the radial approach might be chosen because of severe peripheral vascular disease, operator’s preference or for contralateral injection. The guiding principle of access selection is… View more

MI/ACS

Intervention
EuroPCR’23: BIOADAPTOR RCT results comparing novel DynamX Bioadaptor to Resolute Onyx DES
Author(s): Shigeru Saito , Stefan Verheye Added: 10 months ago
Elixir Medical has announced positive results from the BIOADAPTOR RCT trial, comparing DynamX Bioadaptor to Resolute Onyx DES. The trial met its primary endpoint of TLF non-inferiority at 12 months. The bioadaptor demonstrated a TLF rate of 1.8% compared to 2.8% for the stent (p<0.001) and showed improved vessel function and pulsatility. Principal investigators DrShigeru Saito (Shonan Kamakura… View more

Prevention & Chronic Conditions

Intervention